Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
- PMID: 21352567
- PMCID: PMC3052190
- DOI: 10.1186/1743-422X-8-86
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
Abstract
Background and aims: ELISA is still used as primary test for diagnosis HBV disease. However, ELISA-positive patients were marked as HBV inactive after confirmation with PCR and vice versa. Our aim was to assess the performance of new cut-off value of ALT, HBV DNA load and significance of AST as screening tool for HBeAg (-) chronic active or inactive patients in Pakistani population.
Materials and methods: In a cross-sectional, cohort study, 567 HBeAg (-) patients followed for one year were selected. Patients with persistent elevated ALT than normal and HBV DNA ≥ 100,000 copies/mL were taken as active chronic. Diagnostic values for ALT, AST and HBV DNA load in HBV HBeAg (-) chronic active and inactive patients compared using receiver operation characteristic (ROC) curves.
Results: Of 567 HBeAg (-) patients, 228 were classified as chronic inactive and 339 as active. HBV infection was dominant in male. Serum ALT, AST and HBV DNA levels showed significant and high AUROC to differentiate chronic HBeAg (-) inactive patients from active. AUROC for Serum ALT, AST and HBV DNA were observed 0.997, 0.969 and 1.000, respectively. For revised cut off value for ALT (30 IU/L for male and 19 IU/L for female) and HBV DNA load ≥100,000 copies/mL, a PPV of 97%, NPV of 94%, a sensitivity of 98%, and a specificity of 92% was observed to discriminate active carriers from inactive carriers. We also observed 93.5% specificity, 83.1% sensitivity, 82% PPV and 89.5% NPV for AST ≤20 IU/L to differentiate inactive carriers from active ones in our study group.
Conclusions: Revised cut off value of ALT and NIH derived HBV DNA value can better discriminate between HBeAg (-) chronic active and inactive patients.
Figures


Similar articles
-
Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.World J Gastroenterol. 2009 Jun 28;15(24):3025-31. doi: 10.3748/wjg.15.3025. World J Gastroenterol. 2009. PMID: 19554656 Free PMC article.
-
[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].Mikrobiyol Bul. 2007 Jan;41(1):87-93. Mikrobiyol Bul. 2007. PMID: 17427556 Turkish.
-
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16. J Clin Virol. 2013. PMID: 24004660
-
Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30. Liver Int. 2012. PMID: 22128792
-
The prognosis and management of inactive HBV carriers.Liver Int. 2016 Jan;36 Suppl 1:100-4. doi: 10.1111/liv.13006. Liver Int. 2016. PMID: 26725905 Review.
Cited by
-
Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen.Cancers (Basel). 2020 Feb 10;12(2):409. doi: 10.3390/cancers12020409. Cancers (Basel). 2020. PMID: 32050622 Free PMC article.
-
A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.PLoS One. 2015 Jul 31;10(7):e0134532. doi: 10.1371/journal.pone.0134532. eCollection 2015. PLoS One. 2015. PMID: 26230094 Free PMC article.
-
Characteristics of an Outpatient Cohort with HBeAg-Negative Chronic Hepatitis B.Open Access Maced J Med Sci. 2019 Jul 14;7(13):2068-2074. doi: 10.3889/oamjms.2019.623. eCollection 2019 Jul 15. Open Access Maced J Med Sci. 2019. PMID: 31456827 Free PMC article.
-
The relationship of liver function tests to mixed exposure to lead and organic solvents.Ann Occup Environ Med. 2013 May 21;25(1):5. doi: 10.1186/2052-4374-25-5. Ann Occup Environ Med. 2013. PMID: 24472152 Free PMC article.
-
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection.J Clin Transl Hepatol. 2024 Apr 28;12(4):381-388. doi: 10.14218/JCTH.2023.00378. Epub 2024 Feb 27. J Clin Transl Hepatol. 2024. PMID: 38638381 Free PMC article.
References
-
- Buti M, Sanchez F, Cotrina M, Jardi R, Rodriguez F, Esteban R, Guardia J. Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B. J Infect Dis. 2001;183:1277–1280. doi: 10.1086/319677. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical